ArticleDiabetes & metabolism journal2024

Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients.

Young-Hwan Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.